Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: ILExchange: Nasdaq
DilutionScan read 45 of BioLineRx Ltd.'s SEC filings and found 13 warrant series, 1 ATM program, 1 shelf registration, 1 S-1 registration and 1 completed offering on file for BLRX. The latest dilution event on file is a registration statement on Oct 2, 2026. Analysis updated Oct 12, 2026.
DilutionScan ProEvery instrument in full · $59/mo
Covered companies in Biotechnology. All tickers A to Z
PTNPalatin Technologies, Inc.
INABIN8bio, Inc.
LTRNLantern Pharma Inc.
CLGNCollPlant Biotechnologies Ltd Ordinary Shares
BCLIBrainstorm Cell Therapeutics Inc.
CALCCalciMedica, Inc.
CURXCuranex Pharmaceuticals Inc Common Stock
INTIInhibitor Therapeutics, Inc.
PHIOPhio Pharmaceuticals Corp.
GTBPGT Biopharma, Inc.
ICUSeaStar Medical Holding Corporation
GDTCCytoMed Therapeutics Limited Ordinary Shares
PASGPassage Bio, Inc.
TVRDTvardi Therapeutics, Inc.
TOVXTheriva Biologics, Inc.